WHO pauses hydroxychloroquine trial over safety concerns

ReutersPublished: May 26, 2020 12:04 AM | Updated: May 26, 2020 12:34 AM

CORONAVIRUS | The World Health Organization has suspended testing the malaria drug hydroxychloroquine in Covid-19 patients due to safety concerns, WHO director-general Tedros Adhanom Ghebreyesus said on Monday.

The World Health Organization said on Monday that it has suspended its trial of the malaria drug hydroxychloroquine in Covid-19 patients due to safety concerns.

Trump says he is taking hydroxychloroquine despite FDA warning

Health Ministry to begin clinical trials for Covid-19 treatment

India agrees to sell hydroxychloroquine to Malaysia to help fight Covid-19

DG: Anti-malaria drug may have reduced Covid-19 patients’ need for ICU

Comments0

By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

Do's and don'ts when posting comments in Malaysiakini

TERMS & CONDITIONS

Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

REPORT VIOLATORS

Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

NOTICE

Our commenting system is still under development. We have taken note of feedback provided.

Subscriber-only space: